Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
Vascular Pharmaceuticals Lands $9M For Diabetes Drug Trials 03/03/15 Raleigh Durham
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
Cempra Antibiotic Hits Pneumonia Goals; $100M Stock Sale Planned 01/06/15 Raleigh Durham
Hepatitis C Commercial Game Theory 01/01/15 National
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
In Its Bumpy Second Life, Geron Signs Top Drug Over to J&J 11/13/14 San Francisco
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Rice Consortium Helped Spark Biotech Researchers’ Inner Entrepreneur 11/06/14 Texas
Texas Roundup: “Moon Shots,” TeVido, TMCx, Clarify & Spanning 11/04/14 Texas
Texas Roundup: Mozido, BeatBox, Spinlister, J-Labs, Macheen, Cratejoy 10/27/14 Texas
J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola 10/22/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Influenster Has Its Eyes on Amazon’s Crown for Product Reviews 10/15/14 New York
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program 09/29/14 San Francisco
Page 1 of 12 next page »